OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine
Dawn C. Buse, Paul Winner, Larry Charleston, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Dawn C. Buse, Paul Winner, Larry Charleston, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
Pablo Irimia, Sonia Santos‐Lasaosa, Patricia Pozo‐Rosich, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Pablo Irimia, Sonia Santos‐Lasaosa, Patricia Pozo‐Rosich, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany
Armin Scheffler, P Wenzel, Merle Bendig, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Armin Scheffler, P Wenzel, Merle Bendig, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Predictors of galcanezumab response in a real-world study of Korean patients with migraine
Seung Ae Kim, Hyemin Jang, Mi Ji Lee
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Seung Ae Kim, Hyemin Jang, Mi Ji Lee
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Measuring dose-related efficacy of eptinezumab for migraine prevention: post hoc analysis of PROMISE-1 and PROMISE-2
Rami Apelian, Lee Boyle, Joe Hirman, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Rami Apelian, Lee Boyle, Joe Hirman, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab
Andrew Blumenfeld, Anders Ettrup, Joe Hirman, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Andrew Blumenfeld, Anders Ettrup, Joe Hirman, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review
Délia Szok, Anett Csáti, László Vécsei, et al.
Life (2023) Vol. 13, Iss. 3, pp. 665-665
Open Access | Times Cited: 3
Délia Szok, Anett Csáti, László Vécsei, et al.
Life (2023) Vol. 13, Iss. 3, pp. 665-665
Open Access | Times Cited: 3
Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial
Linus Jönsson, Stephane A. Régnier, Steven Kymes, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 23, Iss. 7, pp. 797-803
Open Access | Times Cited: 3
Linus Jönsson, Stephane A. Régnier, Steven Kymes, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 23, Iss. 7, pp. 797-803
Open Access | Times Cited: 3
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies
Patricia Pozo‐Rosich, David W. Dodick, Anders Ettrup, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Patricia Pozo‐Rosich, David W. Dodick, Anders Ettrup, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Efficacy and safety of eptinezumab 300mg versus 100mg for migraine patients: a meta-analysis of randomized controlled studies
Hongsheng Chen, Wenqing Luo
International Journal of Neuroscience (2022) Vol. 134, Iss. 5, pp. 462-467
Closed Access | Times Cited: 1
Hongsheng Chen, Wenqing Luo
International Journal of Neuroscience (2022) Vol. 134, Iss. 5, pp. 462-467
Closed Access | Times Cited: 1
Predictors of galcanezumab response in a real-world study of Korean patients with migraine
Seung Ae Kim, Hyemin Jang, Mi Ji Lee
Research Square (Research Square) (2023)
Open Access
Seung Ae Kim, Hyemin Jang, Mi Ji Lee
Research Square (Research Square) (2023)
Open Access
